Megan Garlapow, PhD

All articles by Megan Garlapow, PhD

• Researchers uncover new pathway driving myasthenia gravis progression

  Age-associated B cells were found to increase alongside worsening symptoms in patients with MG, suggesting a new way to measure severity.

• Study finds efgartigimod helps cut steroid use while boosting daily function in MG

  Many people with generalized myasthenia gravis were able to reduce or completely stop steroid treatment after starting efgartigimod.

• Recognizing nonmotor symptoms may improve life for people with MG

  Nonmotor symptoms such as cognitive problems and sensory loss are common in myasthenia gravis and can significantly affect daily life.

• Study recommends providing caregivers more support to help MG families thrive

  Caregivers for people with myasthenia gravis (MG) face emotional, physical and financial challenges that affect their own health.

• New tool shows difference in side effect severity for MG treatments

  Patients with MG who took prednisone and azathioprine experienced more treatment side effects than those on prednisone alone.